Presentation Deutsche Bank German & Austrian ... - Gerresheimer

More documents

Recommendations

Info

Europe & North America most important, pharmerging markets gaining in significance 63% Europe (23% <strong>German</strong>y) 24% North America Revenues 2010 EUR 1,025m 13% Other regions 8
Highly attractive end market trends • Aging of world population • Development of healthcare systems in emerging countries • Growing number of acute and chronic diseases • Accelerating pace in drug development • Growth in biotech drugs and generics • Outsourcing trend of drug delivery and primary packaging solutions • Trend towards self-medication 9
Page 1 and 2: Deutsche Bank German & Austrian Cor
Page 3 and 4: Agenda 1 Company description 2 Appe
Page 5 and 6: Clear focus on pharma and healthcar
Page 7: Gerresheimer is a leading global pl
Page 11 and 12: Leading market positions in attract
Page 13 and 14: Gerresheimer’s strategy Organic g
Page 15 and 16: Strong improvement of financial rat
Page 17 and 18: Vedat acquisition in April 2011 mor
Page 19 and 20: Guidance FY 2011 update reflects in
Page 21 and 22: Q1 2011 P&L overview Q1 2011 EUR m
Page 23 and 24: Q1 2011: Adjusted EBITDA 1 and marg
Page 25 and 26: Reconciliation from adjusted EBITDA

Presentation Deutsche Bank German & Austrian ... - Gerresheimer

Create successful ePaper yourself

Delete template?

Save as template?